Categories: NewsPharmaceutical

Oculis updates share capital for its existing at-the-market offering program

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ZUG, Switzerland, Jan. 31, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each with a nominal value of CHF 0.01, issued out of existing capital band (Kapitalband), for an aggregate of 2,500,000 ordinary shares of the Company (the “New Shares”), recorded as treasury shares. The number of registered shares issued by the Company as per its Articles of Association is 48,943,700, of which approximately 43 million shares are outstanding. Following the issuance, the number of treasury shares (own shares) held by the Company is 7.2% of the Company’s registered shares.

The New Shares were issued in relation to the sales agreement between the Company and Leerink Partners LLC (”Leerink Partners”)  entered into on May 8, 2024, with respect to an at-the-market (“ATM”) offering program. Under the ATM offering program, the Company may offer and sell, from time to time at its sole discretion, ordinary shares of the Company having an aggregate offering price of up to $100 million through Leerink Partners as its sales agent. The New Shares have not been sold under the ATM offering program and will be held in reserve as treasury shares.

For more details on the ATM offering program, please refer to the Company’s previous press release dated May 17, 2024, and the Company’s SEC filings referenced therein.

For more information, please visit:
http://www.oculis.com

Oculis Contact:

Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com 

Investor & Media Relations:

LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com 

1-212-915-2577

Staff

Recent Posts

CardioComm Solutions Announces Intention to Settle Outstanding Debt with Issuance of Shares

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or…

3 hours ago

PDS Health and DEXIS Successfully Bring AI-Powered and 3D Imaging to More Than 1,000 Dental Practices Nationwide

Strategic collaboration brings advanced AI and CBCT imaging to more than 1,000 dental practices, enhancing…

10 hours ago

Exactech Reaches Consensual Agreement with Unsecured Creditors Committee, Completes Court Filing of Amended Plan

Plan Confirmation and Sale Approval Court Date Expected in Early September GAINESVILLE, Fla., July 24,…

10 hours ago

MedComms Experts Acquires NexGen Healthcare Communications, Creating a Unified Platform for Strategic Scientific and Commercial Communications

NEW YORK, LONDON, and ZURICH, July 24, 2025 /PRNewswire/ -- MedComms Experts ("MCE"), a global…

10 hours ago

Tali AI Joins QHR’s Marketplace to Bring AI Scribing to Accuro®EMR Users

TORONTO, July 24, 2025 /CNW/ - Tali AI, the leading Canadian healthtech company focused on reducing…

10 hours ago

Diabetes Diagnostics Enters New Era: Kalorama Highlights Digital Shift and Global Surge in HbA1c Testing

ARLINGTON, Va., July 24, 2025 /PRNewswire/ -- The global fight against diabetes is accelerating—and diagnostic innovation…

10 hours ago